Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: alexis s who wrote (113)	8/4/1999 10:57:00 PM
From: John Metcalf	Respond to of 427

"Green shoe" is jargon for an underwriter's overallotment of shares in an IPO, which the issuing company agrees to sell them later under certain circumstances, like the IPO going into the stratosphere. In the case of TSCM, this was about 743,000 shares, bringing the total sold to 6.25 mm.

To: alexis s who wrote (113)	8/4/1999 10:59:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 427

a greenshoe? This is one of the perks underwriters get - it's an option that allows them to buy more shares at the IPO price after the IPO. It's also called an over-allotment option. Don't know where the name came from - anyone know? On a more general note, let's moderate the short/TheStreet-bashing. Of course if they do something else dumb, people may again have a short interlude in which to make their feelings known. <g> Peter